Back to today’s briefing

Story perspectives

Pot Inc. Pushes Trump to Unlock Medical Marijuana Funding

1/10/2026

33 4 Full Breakdown

Summary

Story summary

Pot Inc. plans to lobby the U.S. President Donald Trump's administration, arguing that Wall Street blocks the implementation of his executive order on medical marijuana.
JPMorgan Chase & Co. and Bank of America say they cannot support the marijuana industry until the drug is formally classified as a Schedule III substance.
Marc Cohodes, a former hedge fund manager and proponent of the order, says banks are misinterpreting its intent.

1 of 1

Story summary

Pot Inc. plans to lobby the U.S. President Donald Trump's administration, arguing that Wall Street blocks the implementation of his executive order on medical marijuana.
JPMorgan Chase & Co. and Bank of America say they cannot support the marijuana industry until the drug is formally classified as a Schedule III substance.
Marc Cohodes, a former hedge fund manager and proponent of the order, says banks are misinterpreting its intent.